Changeflow GovPing Pharma & Drug Safety Broad Spectrum Antiviral Compositions and Methods
Routine Notice Added Draft

Broad Spectrum Antiviral Compositions and Methods

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO published patent application US20260092059A1 by Evrys Bio, LLC covering novel thiazole- and isoquinoline-containing compounds for treating broad-spectrum viral infections. The compounds demonstrated inhibition of HCMV, influenza viruses, Zika virus, BK Virus, and RSV in cell-based assays. The application (No. 19342999) was filed September 29, 2025, and published April 2, 2026.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This patent application published by the USPTO discloses novel thiazole- and isoquinoline-containing antiviral compounds and methods of treatment. The claimed compounds showed inhibition of multiple viruses including HCMV, influenza viruses, Zika virus, BK Virus, and RSV in cell-based assays. The application includes six inventors: Stacy Remiszewski, Lillian W. Chiang, Eain Anthony Murphy, Qun Sun, Frank Kayser, and Sarah Jocelyn Fink. CPC classifications include C07D 417/14 and A61K 45/06.

Pharmaceutical companies and researchers developing antiviral therapeutics should review the compound claims and therapeutic applications disclosed. This is a patent application publication, not a granted patent, and represents early-stage intellectual property. Parties interested in the technology or Freedom to Operate considerations should monitor the prosecution status.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

Broad Spectrum Antiviral Compositions and Methods

Application US20260092059A1 Kind: A1 Apr 02, 2026

Assignee

Evrys Bio, LLC

Inventors

Stacy Remiszewski, Lillian W. Chiang, Eain Anthony Murphy, Qun Sun, Frank Kayser, Sarah Jocelyn Fink

Abstract

Novel thiazole- and isoquinoline-containing compounds are presented that are useful for treating and/or preventing broad-spectrum viral infections. Methods of treating and/or preventing broad-specturm viral infections are also presented. These compounds have shown inhibition of HCMV, influenza viruses, Zika virus, BK Virus and RSV replication in cell-based assays.

CPC Classifications

C07D 417/14 A61K 45/06

Filing Date

2025-09-29

Application No.

19342999

View original document →

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260092059A1
Docket
19342999

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Biopharmaceutical Research Drug Development Patent Protection
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Healthcare Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!